Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
329 DKK | +0.92% | +0.12% | +11.15% |
May. 29 | UK’s Competition Regulator Closes Cochlear-Demant Deal | MT |
May. 21 | Denmark's Demant Completes Sale of Cochlear Implants Business | MT |
Sales 2024 * | 23.23B 3.38B | Sales 2025 * | 24.98B 3.63B | Capitalization | 71.62B 10.42B |
---|---|---|---|---|---|
Net income 2024 * | 3.05B 444M | Net income 2025 * | 3.53B 513M | EV / Sales 2024 * | 3.66 x |
Net Debt 2024 * | 13.51B 1.97B | Net Debt 2025 * | 13.39B 1.95B | EV / Sales 2025 * | 3.4 x |
P/E ratio 2024 * |
23.4
x | P/E ratio 2025 * |
19.8
x | Employees | 21,623 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 39.27% |
Latest transcript on Demant A/S
1 day | +0.92% | ||
1 week | +0.12% | ||
1 month | -2.20% | ||
3 months | -4.67% | ||
6 months | +13.29% | ||
Current year | +11.15% |
Managers | Title | Age | Since |
---|---|---|---|
René Schneider
DFI | Director of Finance/CFO | 51 | 15-08-31 |
Niels Jacobsen
BRD | Director/Board Member | 66 | 91-12-31 |
Peter Pudselykke
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 58 | 07-12-31 | |
Niels Jacobsen
BRD | Director/Board Member | 66 | 91-12-31 |
Director/Board Member | 57 | 20-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.55% | 14 M€ | -5.07% | ||
0.14% | 17 M€ | +6.09% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 329 | +0.92% | 882,990 |
24-05-30 | 326 | -.--% | 216,721 |
24-05-29 | 326 | -0.18% | 270,574 |
24-05-28 | 326.6 | -2.51% | 330,257 |
24-05-27 | 335 | +1.95% | 172,284 |
Delayed Quote Nasdaq Copenhagen, May 31, 2024 at 10:59 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.15% | 10.41B | |
+3.79% | 18.79B | |
+8.00% | 14.03B | |
-20.38% | 1.99B | |
+3.10% | 1.76B | |
+8.31% | 1.33B | |
+6.05% | 552M | |
-.--% | 421M | |
+69.47% | 196M | |
+11.28% | 88.9M |
- Stock Market
- Equities
- DEMANT Stock